Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Polydex Pharmaceuticals Ltd (POLXF)

Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Polydex Pharmaceuticals Ltd 421 COMSTOCK ROAD TORONTO A6 M1L 2H5 CAN

www.polydex.com P: 416-755-2231

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Polydex Pharmaceuticals Limited develops and manufactures biotechnology-based products serving markets primarily across North America and globally. The Company primarily focuses on the manufacture and development of Dextran and derivative products. Its product is marketed in human pharmaceutical market and bulk pharmaceutical intermediates for the worldwide pharmaceutical industry. The company was formerly known as Polydex Chemicals Limited and changed its name to Polydex Pharmaceuticals Limited. Polydex Pharmaceuticals Limited is based in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 6,816
Enterprise Value, $K 6,376
Shares Outstanding, K 3,432
Annual Sales, $ 4,400 K
Annual Net Income, $ -770 K
Last Quarter Sales, $ 1,490 K
Last Quarter Net Income, $ -150 K
EBIT, $ -870 K
60-Month Beta 0.44
% of Insider Shareholders 12.90%
% of Institutional Shareholders 0.00%
Float, K 2,989
% Float 87.10%
Short Volume Ratio 1.00

Growth:

1-Year Return 175.83%
3-Year Return 98.60%
5-Year Return 57.62%
5-Year Revenue Growth -16.67%
5-Year Earnings Growth -269.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 06/15/23
Next Earnings Date 01/01/70
Earnings Per Share ttm -0.24
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

POLXF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -16.50%
Return-on-Assets % -13.84%
Profit Margin % -17.50%
Debt/Equity 0.00
Price/Sales 1.54
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 1.41
Interest Coverage -37.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar